-       Report 
- October 2025
-  138 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  393 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  296 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
           -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Clinical Trials 
- July 2025
-  80 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1073EUR$1,200USD£944GBP 
      €1342EUR$1,500USD£1,180GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1073EUR$1,200USD£944GBP 
      €1342EUR$1,500USD£1,180GBP 
            -       Drug Pipelines 
- April 2025
-  60 Pages 
- Global 
   From       €1073EUR$1,200USD£944GBP 
      €1342EUR$1,500USD£1,180GBP 
            -       Clinical Trials 
- April 2025
-  60 Pages 
- Global 
   From       €894EUR$1,000USD£787GBP 
      €1118EUR$1,250USD£983GBP 
            -       Report 
- August 2025
-  180 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- January 2025
-  182 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- January 2025
-  180 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- March 2025
-  219 Pages 
- Global 
   From       €2236EUR$2,500USD£1,967GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
          -       Drug Pipelines 
- June 2025
-  200 Pages 
- Global 
   From       €2495EUR$2,789USD£2,194GBP 
          -       Report 
- September 2025
-  79 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- October 2023
-  157 Pages 
- Global 
   From       €4159EUR$4,650USD£3,659GBP 
          -       Report 
- September 2023
-  180 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
       
      Antithrombotics are drugs used to prevent the formation of blood clots, which can lead to cardiovascular diseases such as stroke and heart attack. These drugs work by inhibiting the activity of clotting factors in the blood, thus preventing the formation of clots. Common antithrombotics include aspirin, clopidogrel, warfarin, and heparin. Aspirin is the most widely used antithrombotic, and is often prescribed to reduce the risk of stroke and heart attack. Clopidogrel is used to prevent blood clots    in patients with coronary artery disease, while warfarin is used to prevent and treat blood clots in patients with atrial fibrillation. Heparin is used to prevent and treat deep vein thrombosis and pulmonary embolism.
The antithrombotics market is highly competitive, with many large pharmaceutical companies offering a range of products. Some of the major players in the market include Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. These companies are continuously developing new products to meet the needs of patients and healthcare providers. Show Less   Read more